Oncology Decoded

Science EN ↓ 30 epizód

CancerNetwork® is excited to announce the launch of Oncology Decoded, a new podcast that will discuss scientific data and practical application in the world of oncology. Hosted by 2 leading experts in the field, Benjamin Garmezy, MD, and Manoj Bupathi, MD, MS, this podcast will cover cutting-edge topics and offer actionable insights to help improve patient outcomes.

Mindenképp látogasd meg a podcast oldalát, és támogasd a készítőjét: audioboom.com

Szerző

Oncology Decoded

Kategória

Science

A podcast weboldala

audioboom.com

Legutóbbi epizód

2026. aug. 21.

Hol hallgathatod?

Podcastok az alkalmazásban Replaio Radio Hamarosan

A podcastok hamarosan megérkeznek az alkalmazásba. Telepítsd most, és láss elsőként egy teljesen új megközelítést a podcastokhoz

Telepítsd ingyen Android közel 10 M letöltés · 4,7+ értékelés iOS hamarosan

Epizódok

5: Beyond Surgery: The Evolving Landscape of Adjuvant Therapy in Kidney Cancer 01.05.2025 33:42

Manojkumar Bupathi, MD, MS; and Benjamin Garmezy, MD, dove into the complexities of adjuvant therapy for kidney cancer, providing valuable insights for oncology clinicians in the latest episode of Oncology Decoded . The discussion began with a fundamental overview of adjuvant therapy, which aims to eradicate residual microscopic disease and mitigate the risk of cancer recurrence. Bupathi, execu...

4: Adjuvant Therapy and Post-Surgical Management Options for Kidney Cancer 01.04.2025 38:59

In the most recent episode of Oncology Decoded , co-hosts Manojkumar Bupathi, MD, MS, executive co-chair of Genitourinary Cancer Research Executive Committee at Sarah Cannon Research Institute and medical oncologist with Rocky Mountain Cancer Centers specializing in solid tumors and genitourinary cancers; and Benjamin Garmezy, MD, associate director of Genitourinary Research and executive co-chair...

3: Traversing the Complexities of Non-Clear Cell Renal Cell Carcinoma 07.03.2025 25:30

This episode of Oncology Decoded tackled the challenging landscape of non-clear cell renal cell carcinoma (nccRCC), a heterogeneous group of tumors representing about 20% to 25% of all kidney cancers. The episode provided expert insights into the diagnosis and management of this complex disease. Meet the panel discussants: Manojkumar Bupathi, MD, MS, executive co-chair of Genitourinary Cancer Re...

2: Navigating Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer 05.03.2025 26:21

When treating hormone-sensitive prostate cancer (mHSPC), one question can be, when is the right time to optimize or intensify therapy? In the latest Oncology Decoded podcast, genitourinary oncologists discuss the use of radiotherapy and define oligometastatic disease including preferred treatment options. The discussion took place during the 2025 ASCO Genitourinary Cancers Symposium. The expert p...

1: NIAGARA Study is the Forefront of Post-ASCO GU Discussion in Bladder Cancer 04.03.2025 33:13

During the 2025 ASCO Genitourinary Cancers Symposium, Oncology Decoded held their inaugural podcast with a live filming taking place at the conference. The first episode focused on bladder cancer specifically, neoadjuvant vs adjuvant therapy options and the use of cisplatin vs carboplatin. Meet the expert panel involved in the discussion: Manojkumar Bupathi, MD, MS, executive co-chair of Geni...